Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBGK7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,040
Award facts
- Contract value 100% obligated
- $70,039.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $70,039.65 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors on January 14, 2026, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Cosentyx is a biologic immunosuppressant medication used to treat autoimmune and inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This delivery order reflects DLA's ongoing pharmaceutical procurement operations to maintain adequate supplies of specialty medications for military treatment facilities and veterans' healthcare programs. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, plays a critical role in the federal medical supply chain, leveraging its extensive product portfolio and distribution capabilities to fulfill government healthcare requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FBGK7?
SPE2DR26FBGK7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FBGK7 worth?
The government has obligated $70,040 on SPE2DR26FBGK7.
Is contract SPE2DR26FBGK7 an order under another contract?
Yes. SPE2DR26FBGK7 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBGK7 competed?
The extent of competition for SPE2DR26FBGK7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award